Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells

Cell Growth and Differentiation

Volumn 7, Issue 3, 1996, Pages 397-404

  Singh, Rakesh K ^a   Llansa, Norma ^a   Bucana, Corazon D ^a   Sanchez, Ricardo ^a   Koura, Aaryan ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS;

CARCINOMA, RENAL CELL; CELL COMMUNICATION; CELL COUNT; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; KINETICS; RNA, MESSENGER; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 0029851233     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Folkman, J. Angiogenesis in cancer, vascular rheumatoid and other diseases. Nat. Med., 1: 27-31, 1995.
2. Folkman, J., and Klagsburn, M. Angiogenic factors. Science (Washington DC), 235: 444-447, 1987.
3. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3: 65-71, 1992.
4. Fidler, I. J , and Ellis, L. M. The implications of angiogenesis to the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
5. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis. correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
6. Weidner, N , Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gaspanni, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma J Natl. Cancer Inst., 84, 1875-1887, 1992.
7. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am. J Pathol., 743: 401-409, 1993.
8. Graham, C. H., Rivers, J., Kerbel, R. S., Stankiewicz, K. S., and White, W. L. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanoma. Am. J. Pathol., 145: 510-514, 1994.
9. Weidner, N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin. Diagn. Pathol., 10: 302-313, 1993.
10. Gasparini, G., and Hams, H. L. Clinical importance of determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol., 13. 765-782, 1995.
11. Statuto, M., Ennas, M. G., Zamboni, Z., Bonetti, F., Pea, M., Berhardello, F., Pozzo, A., Rusnati, M., Gualandris, A., and Presta, M Basic fibroblast growth factor in human pheochromocytoma: a biochemical and immunohistochemical analysis. Int. J. Cancer, 53: 5-10, 1993.
12. Yamanishi, D. T., Graham, M. J., Florkiewicz, R. Z., Buckmeier, J. A., and Meyskens, F. L., Jr. Differences in basic fibroblast growth factor mRNA and protein levels in human primary melanocytes and metastatic melanoma cells. Cancer Res , 52: 5024-5029, 1992.
13. Singh, R K., Bucana, C D., Gutman, M , Fan, D., Wilson, M. R., and Fidler, I. J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Pathol., 145: 365-374, 1994.
14. Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., and Fidler, I. J. Interferon-α and -β downregulate the expression of basic fibroblast growth factor in human carcinomas Proc. Natl. Acad. Sci. USA, 92: 4562-4566, 1995.
15. Verrelle, P., Meissonnier, F., Fonck, Y., Feillel, V., Dionet, C., Kwiatkowski, F., Plagne, R., and Chassagne, J. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl. Cancer Inst., 83: 111-116, 1991.
16. Weinstien, R. S., Jakate, S. M., Dominguez, J. M., Lebovitz, M. D., Koukoulis, G. K., Kuszak, J. R., Flusens, L. F., Grogan, T M., Saclarides, T. J., Roninson, I. B., and Coon, J S. Relationship of the expression of the muitidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res , 51: 2720-2726, 1991.
17. Wooley, D. E. Collagenolytic mechanisms in tumor cell invasion. Cancer Metastasis Rev., 3: 361-372, 1984.
18. Tryggvason, K., Hoytya, M., and Pyke, C. Type IV collagenase in invasive tumors. Breast Cancer Res. Treat., 24: 209-218, 1993.
19. Nanus, D. M., Schmitz-Dragerm, B. J., Motzer, R. J., Lee, A. C., Vlamis, V., Cordon-Cardo, C., Albino, A. P., and Reuter, V. E. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. Natl. Cancer Inst., 85: 1597-1599, 1994.
20. Soprano, K. J. W1-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth. J. Cell. Biochem., 54, 405-414, 1994.
21. 1 events and regulation of cell proliferation. Science (Washington DC), 246: 603-608, 1989.
22. Baserga, R. The Biology of Cell Reproduction. Cambridge, MA: Harvard University Press, 1985.
23. Williams, J. G., and Penman, S. The messenger RNA sequences in growing and resting mouse fibroblasts. Cell, 6: 197-206, 1975.
24. Schneider, C., King, R. M., and Phihpson, L Genes specifically expressed at growth arrest of mammalian cells. Cell, 54: 787-793, 1988.
25. Xie, B , Bucana, C. D., and Fidler, I. J. Density-dependent induction of 92-kd type IV collagenase activity in culture of A431 human epidermoid carcinoma cells. Am J Pathol., 144: 1058-1067, 1994
26. Murphy, P. R., Sato, R., Sato, Y., and Friesen, H. G. Fibroblast growth factor messenger ribonucleic acid expression in a human astrocytoma cell line: regulation by serum and cell density. Mol. Endocrinol., 2. 591-598, 1988.
27. Bost, L. M., and Hjelmeland, L. M. Cell density regulates differential production of bFGF transcripts. Growth Factors, 9: 195-203, 1993.
28. Tomasz, M., Lipman, R., Chowdary, D., Pawlak, J., Verdine, G. L , and Nakamishi, K. Isolation and structure of covalent crosslink adduct between mitomycin C and DNA Science (Washington DC), 235: 1204-1208, 1987.
29. Mulder, K. M. Differential regulation of c-myc and transforming growth factor-α messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state. Cancer Res., 51: 2256-2262, 1991.
30. Dean, M., Levine, R. A., Ran, W., Kindy, M. S., Sonenshein, G. E., and Campisi, J. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J. Biol. Chem., 261: 9161-9166, 1986.
31. Clement, A., Campisi, J., Farmer, S. R , and Brody, J. S. Constitutive expression of growth-related mRNAs in proliferating and nonproliferating lung epithelial cells in primary culture: evidence for growth-dependent translational control. Proc. Natl. Acad. Sci. USA, 87: 318-322, 1990.
32. Bjorge, J. D., Paterson, A. J., and Kudlow, J. E. Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-α in a breast cancer cell line. J. Biol Chem., 264: 4021-4027, 1989.
33. Coffey, R. J., Jr., Derynck, R., Wilcox, J. N., Bringman, T. S., Goustin, A. S., Moses, H. L., and Pittelkow, M. R. Production and auto-induction of transforming growth factor-α in human keratinocytes. Nature (Lond.), 328: 817-820, 1987.
34. Muller, C., Laval, F., Soues, S., Birck, C., and Charcosset, J-Y. High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells. Biochem. Pharmacol., 43: 2091-2102, 1992.
35. 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Exp. Cell Res., 214: 215-224, 1994.
36. Lin, M-F., Garcia-Arenas, R., Kawachi, M., and Lin, F-F. Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells. Cell. Mol Biol. Res., 39: 739-750, 1993.
37. Bennett, M. R., Littlewood, T. D , Hancock, D. C., Evan, G. I., and Newby, A. C. Downregulation of the c-myc protooncogene in inhibition of vascular smooth-muscle cell proliferation. A signal for growth arrest? Biochem. J., 302: 701-708, 1994.
38. Östman, A., Yang, Q., and Tonks, N. K. Expression of DEP-1, a receptor-like protein tyrosine phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA, 91: 9680-9684, 1994.
39. Baird, A., and Durkin, T. Inhibition of endothelial cell proliferation by type β transforming growth factor interactions with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Commun., 138: 476-482, 1986.
40. Stoker, M. G., and Rubin, H. Density-dependent inhibition of cell growth in culture. Nature (Lond.), 215: 171-172, 1967.
41. Fantl, W. J., Johnson, D. E., and Williams, L. T. Signalling by receptor tyrosine kinases. Annu. Rev. Biochem., 62: 453-481, 1993.
42. Tonks, N. K. (ed.). Introduction. Protein tyrosine phosphatases. Semin. Cell Biol., 4: 373-453, 1993.
43. Alexandrow, M G., and Moses, H L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55: 1452-1457, 1995.
44. Zen, K., Masuda, J., Sasaguri, T., Kosaka, C., and Ogata, J. Gene expression of monocyte chemoattractant protein-1 in human monocytes is regulated by cell density through protein tyrosine kinase and protein kinase C. Exp. Cell Res., 215: 172-179, 1994.
45. Hunter, T. Protein kinases and phosphatases. The ying and yang of protein phosphorylation and signaling. Cell, 80: 225-236, 1995.
46. 1 phase of the cell cycle. J. Cell Biol., 101: 2194-2198, 1985.
47. Muller, R., Bravo, R., Burckhardt, J., and Curran, T. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (Lond.), 312: 716-720, 1984
48. Shibata, F., Baird, A., and Florkiewicz, R. Z. Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors, 4: 277-287, 1991.
49. Hay, N., Bishop, J. M., and Levens, D. Regulatory elements that modulate expression of human c-myc. Genes & Dev., 1: 659-671, 1987.
50. Hay, N., Takimoto, M., and Bishop, J. M. A FOS protein is present in a complex that binds a negative regulator of MYC. Genes & Dev., 3: 293-303, 1989.
51. Naito, S., von Eschenbach, A. C., Giavazzi, R., and Fidler, I. J. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res., 46: 4109-4115, 1986.
52. Naito, S., Walker, S., and Fidler, I. J. In vivo selection of human renal carcinoma cells with high metastatic potential in nude mice Clin. Exp Metastasis, 7: 381-389, 1989.
53. Radinsky, R., Kraemer, P. M., Raines, M. A., Kung, H J., and Culp, L A. Amplification and rearrangement of Kirsten ras oncogene in virus transformed BALB/3T3 cells during malignant tumor progression. Proc. Natl. Acad. Sci. USA, 84: 5143-5147, 1987.
54. Fort, P., Marty, L., Liechaczyk, M., Sabrouty, S. E., Dani, C., and Blanchard, J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphatidehydrogenase multigene family Nucleic Acids Res., 13: 1431-1442, 1985.
55. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagsburn, M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.), 331: 173-175, 1988.
56. Feinberg, A P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.